M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis

PLoS Neglected Tropical Diseases

Volumn 9, Issue 10, 2015, Pages

  Mukhopadhyay, Debanjan ^a   Mukherjee, Shibabrata ^a   Roy, Susmita ^a   Dalton, Jane E ^b   Kundu, Sunanda ^a   Sarkar, Avijit ^a   Das, Nilay K ^c   Kaye, Paul M ^b   Chatterjee, Mitali ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b UNIVERSITY OF YORK   (United Kingdom)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY GLUCONATE; ARGINASE 1; CD14 ANTIGEN; CD68 ANTIGEN; COLECALCIFEROL; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 4; MANNOSE RECEPTOR; MESSENGER RNA; MILTEFOSINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL PLASTICITY; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HOMEOSTASIS; HOST RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; IN VITRO STUDY; LEISHMANIA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS; CELL DIFFERENTIATION; COMPLICATION; GENE EXPRESSION PROFILING; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INDIA; MIDDLE AGED; VERY ELDERLY; VISCERAL LEISHMANIASIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CHILD; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOSUPPRESSION; INDIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; YOUNG ADULT;

EID: 84959190328     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004145     Document Type: Article

References (51)

1. Mukhopadhyay D, Dalton JE, Kaye PM, Chatterjee M, Post kala-azar dermal leishmaniasis: an unresolved mystery. Trends Parasitol. 2014;30: 65–74. doi: 10.1016/j.pt.2013.12.00424388776
2. Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM, Post kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003;3: 87–98. 12560194
3. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M, Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013;229: 176–185. doi: 10.1002/path.413323096265
4. Martinez FO, Helming L, Gordon S, Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27: 451–483. doi: 10.1146/annurev.immunol.021908.13253219105661
5. Pearce EJ, MacDonald AS, The immunobiology of schistosomiasis. Nat Rev Immunol. 2002;2: 499–511. 12094224
6. Biswas SK, Chittezhath M, Shalova IN, Lim JY, Macrophage polarization and plasticity in health and disease. Immunol Res. 2012;53: 11–24. doi: 10.1007/s12026-012-8291-922418728
7. Hölscher C, Arendse B, Schwegmann A, Myburgh E, Brombacher F, Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice. J Immunol. 2006;176: 1115–1121. 16394000
8. Abebe T, Hailu A, Woldeyes M, Mekonen W, Bilcha K, Cloke T, et al. Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia. PLoS Negl Trop Dis. 2012; 6: e1684. doi: 10.1371/journal.pntd.000168422720104
9. Abebe T, Takele Y, Weldegebreal T, Cloke T, Closs E, Corset C, et al. Arginase activity—a marker of disease status in patients with visceral leishmaniasis in Ethiopia. PLoS Negl Trop Dis. 2013;7: e2134. doi: 10.1371/journal.pntd.000213423556019
10. França-Costa J, Van Weyenbergh J, Boaventura VS, Luz NF, Malta-Santos H, Oliveira MC, et al. Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis. J Infect Dis. 2015;211: 426–435. doi: 10.1093/infdis/jiu45525124926
11. Raes G, Van den Bergh R, De Baetselier P, Ghassabeh GH, Scotton C, Locati M, et al. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J Immunol. 2005;174: 6561. 15905489
12. Martinez FO, Helming L, Milde R, Varin A, Melgert BN, Draijer C, et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood. 2013;121: e57–69. doi: 10.1182/blood-2012-06-43621223293084
13. Mukhopadhyay D, Das NK, Roy S, Kundu S, Barbhuiya JN, Chatterjee M, Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasis. J Infect Dis. 2011;204: 1427–1436. doi: 10.1093/infdis/jir55121933878
14. Sarkar A, Saha P, Mandal G, Mukhopadhyay D, Roy S, Singh S.K, et al. Monitoring of intracellular nitric oxide in leishmaniasis: its applicability in patients with visceral leishmaniasis. Cytometry A. 2011;79: 35–45. doi: 10.1002/cyto.a.2100121182181
15. Sarkar A, Mandal G, Singh N, Sundar S, Chatterjee M, Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate. Exp Parasitol. 2009;122: 299–305. doi: 10.1016/j.exppara.2009.04.01219393240
16. Kundu S, Bala A, Ghosh P, Mukhopadhyay D, Mitra A, Sarkar A, et al. Attenuation of oxidative stress by allylpyrocatechol in synovial cellular infiltrate of patients with Rheumatoid Arthritis. Free Radic Res. 2011;45: 518–526. doi: 10.3109/10715762.2011.55548021284489
17. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116: e74–80. doi: 10.1182/blood-2010-02-25855820628149
18. Gordon S, Alternative activation of macrophages. Nat Rev Immunol. 2003;3: 23–35. 12511873
19. Sica A, Mantovani A, Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122: 787–795. doi: 10.1172/JCI5964322378047
20. Chawla A, Control of macrophage activation and function by PPARs. Circ. Res. 2010;106: 1559–1569.
21. Ansari NA, Ramesh V, Salotra P, Interferon (IFN)-gamma, tumor necrosis factor-alpha, interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J Infect Dis. 2006;194: 958–965. 16960784
22. Yoshinaga K, Obata H, Jurukovski V, Mazzieri R, Chen Y, Zilberberg L, et al. Perturbation of transforming growth factor (TGF)-beta1 association with latent TGF-beta binding protein yields inflammation and tumors. Proc Natl Acad Sci U S A. 2009;105: 18758–18763.
23. Mukherjee S, Mukhopadhyay D, Braun C, Barbhuiya JN, Das NK, Chatterjee U, et al. Decreased presence of Langerhans cells are critical determinants for Indian Post kala-azar dermal leishmaniasis. Exp Dermatol. 2015;24: 232–234. doi: 10.1111/exd.1263525580856
24. Griffin MD, Xing N, Kumar R, Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23: 117–145. 12651965
25. Bhattacharya P, Gupta G, Majumder S, Adhikari A, Banerjee A, Halder K, et al. Arabinosylated lipoarabinomannan skews Th2 phenotype towards Th1 during Leishmania infection by chromatin modification: involvement of MAPK signaling. PLoS One. 2011;6: e24141. doi: 10.1371/journal.pone.002414121935379
26. Roy S, Mukhopadhyay D, Mukherjee S, Ghosh S, Kumar S, Sarkar K, et al. A defective oxidative burst and impaired antigen presentation are hallmarks of human Visceral Leishmaniasis. J Clin Immunol. 2015;35: 56–67.
27. Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, Majumdar S, et al. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat. Immunol. 2009;10: 273–280. doi: 10.1038/ni.170519198591
28. Novais FO, Nguyen BT, Beiting DP, Carvalho LP, Glennie ND, Passos S, et al. Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species. J Infect Dis. 2014;209: 1288–1296. doi: 10.1093/infdis/jiu01324403561
29. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M, The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25: 677–686. 15530839
30. Scott AL, The alternatively activated human-redux. J Infect Dis. 2009;199: 1723–1725. doi: 10.1086/59909119456228
31. Babu S, Kumaraswami V, Nutman TB, Alternatively activated and immunoregulatory monocytes in human filarial infections. J Infect Dis. 2009;199: 1827–1837. doi: 10.1086/59909019456233
32. Stempin CC, Dulgerian LR, Garrido VV, Cerban FM, Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals. J Biomed Biotechnol. 2010;2010: 683485. doi: 10.1155/2010/68348520029630
33. Osorio EY, Zhao W, Espitia C, Saldarriaga O, Hawel L, Byus CV, et al. Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression. PLoS Pathog. 2012;8: e1002417. doi: 10.1371/journal.ppat.100241722275864
34. Osorio EY, Travi BL, da Cruz AM, Saldarriaga OA, Medina AA, Melby PC, Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis. PLoS Pathog. 2014;10: e1004165. doi: 10.1371/journal.ppat.100416524967908
35. Kaye P, Scott P, Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol. 2011;9: 604–615. doi: 10.1038/nrmicro260821747391
36. Lambertz U, Silverman JM, Nandan D, McMaster WR, Clos J, Foster LJ, et al. Secreted virulence factors and immune evasion in visceral leishmaniasis. J Leukoc Biol. 2012;91: 887–899. doi: 10.1189/jlb.061132622442494
37. Beattie L, d'El-Rei Hermida M, Moore JW, Maroof A, Brown N, Lagos D, et al. A transcriptomic network identified in uninfected macrophages responding to inflammation controls intracellular pathogen survival. Cell Host Microbe. 2013;14: 357–368. doi: 10.1016/j.chom.2013.08.00424034621
38. Chan MM, Adapala N, Chen C, Peroxisome Proliferator-Activated Receptor-γ-mediated polarization of macrophages in Leishmania infection. PPAR Res. 2012;2012: 796235. doi: 10.1155/2012/79623522448168
39. Brüne B, Dehne N, Grossmann N, Jung M, Namgaladze D, Schmid T, et al. Redox control of inflammation in macrophages. Antioxid Redox Signal. 2013;19: 595–637. doi: 10.1089/ars.2012.478523311665
40. Bouhlel MA, Derudas B, Rigamonti E, Dièvart R, Brozek J, Haulon S, et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007;6: 137–143. 17681149
41. Wollenberg A, Mommaas M, Oppel T, Schottdorf EM, Günther S, Moderer M, Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J Invest Dermatol. 2002;118: 327–334. 11841552
42. Angel CE, Lala A, Chen CJ, Edgar SG, Ostrovsky LL, Dunbar PR, CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts. Int Immunol. 2007;19: 1271–1279. 17804688
43. Gupta R, Kushawaha PK, Samant M, Jaiswal AK, Baharia RK, Dube A, Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses. J Antimicrob Chemother. 2012;67: 440–443. doi: 10.1093/jac/dkr48522121191
44. Saha S, Mondal S, Ravindran R, Bhowmick S, Modak D, Mallick S, et al. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol. 2007;179: 5592–5603. 17911647
45. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006;36: 361–370. 16402404
46. Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW, et al.Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188: 2127–2135. doi: 10.4049/jimmunol.110241222301548
47. Mantovan A, Sica A, Locati M, Macrophage polarization comes of age. Immunity. 2005;23: 344–346. 16226499
48. Do JE, Kwon SY, Park S, Lee ES, Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology. 2008;47: 840–848. doi: 10.1093/rheumatology/ken10918411217
49. Ehrchen J, Helming L, Varga G, Pasche B, Loser K, Gunzer M, et al.Vitamin D receptor signalling contributes to susceptibility to infection with Leishmania major. FASEB J. 2007;21: 3208–3218. 17551101
50. Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. 2011;121: 985–997. doi: 10.1172/JCI4449021317534
51. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A, Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol.2002;23: 549–55. 12401408